KLK3 and neoplasm: Identifying recurrence early, particularly at PSA levels near the Phoenix threshold (defined as a rise of ≥2 ng/mL above the post-treatment nadir PSA, according to the RTOG-ASTRO Phoenix criteria), can allow for timely intervention during a less advanced stage of tumor evolution [16].